BioSpace News Archive

Collaboration will Leverage Access to the NURTuRE Patient Biobank and Evotec’s PanHunter Multi-Omics Platform to Characterize Molecular Drivers, Identify and Validate Novel Targets and Drive Patient Stratification Strategies in Kidney Disease Collaboration Will Focus on Polycystic Kidney Disease (PKD), Lupus Nephritis, IgA Nephropathy and Other Primary Glomerular Diseases

LFB today announced that the European Medicines Agency (EMA), the European regulatory authority, has accepted for filing the Marketing Authorization Application for eptacog beta, a recombinant coagulation Factor VIIa (rFVIIa).

Benefitfocus, Inc. (NASDAQ: BNFT), an industry-leading benefits technology platform that simplifies benefits administration for employers, health plans and brokers, has published an ebook containing highlights of a study identifying superior customer experiences, strategies, operating models and capabilities health insurers can adopt to address engagement expectations of a changing member population

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced it will be featured as a presenting company at the Bank of America 2021 Virtual Global Agriculture & Materials Conference being held on March 3-4, 2021. On Thursday, March 4, 2021 at 7:00 am Eastern Time,

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the fourth quarter and full year ended December 31, 2020 on Tuesday, March 9, 2021, and host a conference call and webcast at 8:30 am Eastern Time.

AllianceRx Walgreens Prime recently announced results from research analyzing data of females with multiple sclerosis (MS) who became pregnant, and the impact of adherence to their disease-modifying therapies (DMTs) on hospital utilization and cost

The Urology Care Foundation, the official Foundation of the American Urological Association, is calling on the public to make a commitment to the health of their kidneys – especially during COVID-19 - by taking a pledge and sharing it with others at www.urologyhealth.org/kidneyhealth.

Wugen Inc., a biotechnology company developing novel, universal allogeneic off-the-shelf cell therapies, today announced the appointment of the company’s co-founder, Matt Cooper, Ph.D., as the Chief Scientific Officer (CSO).

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces the appointment of Paul Maier as Non-Executive Director of the Board. Mr Maier will also be a member of 4D’s Audit and Risk Committee and will serve as the Company’s “audit committee financial expert”

Gamida Cell Announces Results from Phase 3 Study of Omidubicel to be Presented at the 47 th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)